IRIS
BRAVACCINI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 726
EU - Europa 561
NA - Nord America 377
SA - Sud America 107
AF - Africa 6
OC - Oceania 2
Totale 1.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 362
SG - Singapore 353
HK - Hong Kong 348
IE - Irlanda 311
BR - Brasile 102
DE - Germania 64
IT - Italia 60
NL - Olanda 26
FI - Finlandia 22
FR - Francia 20
AT - Austria 10
CA - Canada 10
RU - Federazione Russa 10
GB - Regno Unito 9
BE - Belgio 6
CZ - Repubblica Ceca 6
LT - Lituania 6
CN - Cina 5
MX - Messico 5
IQ - Iraq 4
TR - Turchia 3
UA - Ucraina 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
IN - India 2
KG - Kirghizistan 2
PL - Polonia 2
TN - Tunisia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CO - Colombia 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
MA - Marocco 1
PK - Pakistan 1
SN - Senegal 1
VN - Vietnam 1
Totale 1.779
Salva come PNG Salva come JPEG
Città #
Hong Kong 346
Dublin 311
Santa Clara 130
Boardman 129
Singapore 126
Munich 24
Helsinki 22
Amsterdam 19
Assago 18
Ashburn 13
Frankfurt am Main 12
Milan 10
São Paulo 9
Düsseldorf 8
Vienna 8
Brno 6
Brussels 6
Belo Horizonte 5
Chicago 5
Lugo 5
Paris 5
Toronto 5
Ottawa 4
Brasília 3
Juiz de Fora 3
Lauterbourg 3
London 3
Pescara 3
Portsmouth 3
Americana 2
Baku 2
Bishkek 2
Campinas 2
Caxias do Sul 2
Lecce 2
Mexico City 2
Nuremberg 2
Ponsacco 2
Porto Alegre 2
Ribeirão Preto 2
São Lourenço 2
São Sebastião do Paraíso 2
Tashkent 2
Abakan 1
Almirante Tamandaré 1
Apodi 1
Aracaju 1
Aryanah 1
Atibaia 1
Barretos 1
Belford Roxo 1
Belo Jardim 1
Betim 1
Bhubaneswar 1
Birmingham 1
Bogotá 1
Botucatu 1
Brovary 1
Cabo Frio 1
Candói 1
Cape Town 1
Caracas 1
Chihuahua City 1
Crescentino 1
Dakar 1
Desenzano del Garda 1
Diadema 1
Elias Fausto 1
Fazenda Rio Grande 1
Florence 1
Forquilhinha 1
Fuzhou 1
Garanhuns 1
Gatchina 1
Governador Valadares 1
Gravataí 1
Guareí 1
Guarujá do Sul 1
Hortolândia 1
Ibiassucê 1
Isidro Casanova 1
Itaboraí 1
Itajaí 1
Itajubá 1
Itapema 1
Itapetininga 1
Itaquaquecetuba 1
Ituiutaba 1
Izhevsk 1
Janaúba 1
Joinville 1
João Pessoa 1
Kalesija 1
Lahore 1
Lajedo 1
Limeira 1
Los Angeles 1
Madrid 1
Maraial 1
Mauriti 1
Totale 1.329
Salva come PNG Salva come JPEG
Nome #
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? 68
The use of platelets as a clinical tool in oncology: opportunities and challenges 39
Biomarkers: which ones do we really need today? 32
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study 26
Urinary Biomarkers in Tumors: An Overview 26
Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer 25
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter 24
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota 23
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 23
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 23
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 23
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study 23
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors 23
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa 22
TMB in NSCLC: A Broken Dream? 20
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer 20
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer 20
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? 20
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer 20
Androgen receptor in breast cancer: The "5W" questions 20
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer 19
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection 19
Are we ready to use TMB in breast cancer clinical practice? 19
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution 19
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer 19
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer 18
Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa 18
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus 18
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study 18
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis 18
Androgen receptor signaling pathways as a target for breast cancer treatment 18
An H-1 NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 18
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit) 18
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? 17
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance 17
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country 17
Molecular characterization of cytotoxic and drug resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines 17
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 17
Relevance of urine telomerase in the diagnosis of bladder cancer 17
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells 16
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) 16
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? 16
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects 16
Combined analysis of miR-200 family and its significance for breast cancer 16
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls 16
Usefulness of immunological detection of the human telomerase reverse transcriptase 16
Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR) 16
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 16
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling 16
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 16
Urine telomerase: An important marker in the diagnosis of bladder cancer 15
Expanding Roles of De Novo Lipogenesis in Breast Cancer 15
What to look for in cell-free DNA from breast cancer patients 15
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data 15
International consensus on severe lung cancer-the first edition 15
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity 15
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance 15
Urinary biomarkers of nonmuscle-invasive bladder cancer: current status and future potential 15
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer 15
Sorafenib for the treatment of breast cancer 15
Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression 15
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 14
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 14
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design 14
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. 14
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer 14
Why the complications of COVID-19 patients differ in elderly and young cancer patients 14
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro 14
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy 13
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China 13
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer 13
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma 13
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 13
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer 12
Primary epithelioid angiosarcoma of the thyroid: A case report 12
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization 12
What's the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors? 12
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 12
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA 12
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue 12
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients 12
CAR T cells targeting options in the fight against multiple myeloma 12
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy 12
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold 12
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer" 12
Benefit from anthracyclines in relation to biological profiles in early breast cancer 12
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? 12
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 12
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report 11
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer A case report 11
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology 11
Biofunctional characteristics of in situ and invasive breast carcinoma 11
Unraveling the protein kinase C/NDRG1 signaling network in breast cancer. 11
FAP inhibitors: are we really using the best method to evaluate the residence time? 11
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough? 11
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinomain situ 11
Progress with palbociclib in breast cancer: latest evidence and clinical considerations 11
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 11
Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable? 11
Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania 11
Totale 1.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024187 0 0 0 0 0 0 0 0 0 0 0 187
2024/20251.832 264 71 193 57 234 318 149 135 304 107 0 0
Totale 2.019